Evaluation of serological platelet antibody assaysKAPLAN, C.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 355-358, issn 0042-9007, SUP2Conference Paper

Mass media and health servicesKARHU, M.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 111-113, issn 0042-9007, SUP2Conference Paper

Alternatives to human blood and blood resourcesPROWSE, C. V.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 21-28, issn 0042-9007, SUP2Conference Paper

Experiences with self service electronic blood bankingCHENG, G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 427-429, issn 0042-9007, SUP2Conference Paper

Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentratesCORASH, L.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 173-176, issn 0042-9007, SUP2Conference Paper

Organizational changes in EstoniaEVERAUS, H.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 531-533, issn 0042-9007, SUP2Conference Paper

Screening programmes for foetomaternal alloimmune thrombocytopeniaWILLIAMSON, L. M.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 385-389, issn 0042-9007, SUP2Conference Paper

Transmission of parasites by blood transfusionDODD, R. Y.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 161-163, issn 0042-9007, SUP2Conference Paper

Factors determining quality of plasmaMYLLYLÄ, G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 507-511, issn 0042-9007, SUP2Conference Paper

Microbiological safety of blood transfusionBARBARA, J. A. J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 11-13, issn 0042-9007, SUP2Conference Paper

Complement and biocompatibilityMOLLNES, T. E.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 303-307, issn 0042-9007, SUP2Conference Paper

GMP in blood collection and processingWAGSTAFF, W.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 513-521, issn 0042-9007, SUP2Conference Paper

Immunomodulatory effects of allogeneic blood transfusions : Clinical manifestations and mechanismsBLAJCHMAN, M. A.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 315-319, issn 0042-9007, SUP2Conference Paper

Molecular genetic methods : Principles and feasibility in Transfusion MedicineAVENT, N. D.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 275-284, issn 0042-9007, SUP2Conference Paper

Virus inactivation of fresh plasmaMOHR, H.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 171-172, issn 0042-9007, SUP2Conference Paper

What future means to management of blood centresVAN AKEN, W. G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 115-118, issn 0042-9007, SUP2Conference Paper

The CD34 molecule and hematopoietic progenitor cell studies : a challenge in clinical medicineEGELAND, T.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 467-468, issn 0042-9007, SUP2Conference Paper

The transfusion medicine consultant and hospital transfusion committeePOPOVSKY, M. A.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 391-393, issn 0042-9007, SUP2Conference Paper

From Karl Landsteiner to human xenotransplantationSAMUEISSON, B.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 65-68, issn 0042-9007, SUP2Conference Paper

A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newbornHADLEY, A. G.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 375-383, issn 0042-9007, SUP2Conference Paper

Blood Collection and the labile blood components : What should the regulators ask for?MANIATIS, A; ADAMIDES, E.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 523-525, issn 0042-9007, SUP2Conference Paper

Interactions between science, government and media on selection and testing of donorsSAZAMA, K.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 503-506, issn 0042-9007, SUP2Conference Paper

Modified hemoglobin-based blood substitutes : Crosslinked, recombinant and encapsulated hemoglobinCHANG, T. M. S.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 233-241, issn 0042-9007, SUP2Conference Paper

Replacement of massive blood lossHIIPPALA, S.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 399-407, issn 0042-9007, SUP2Conference Paper

Page / 3